FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Carol Wikstrand

Research Profile

Chemicals & Drugs

Disorders

Living Beings

Anatomy

Procedures

Concepts & Ideas

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Chien-Tsun Kuan; Kenji Wakiya; James E Herndon; Eric S Lipp; Charles N Pegram; Gregory J Riggins; Ahmed Rasheed; Scott E Szafranski; Roger E McLendon; Carol J Wikstrand; Darell D Bigner
MRP3: a molecular target for human glioblastoma multiforme immunotherapy.
Chien-Tsun Kuan; Carol J Wikstrand; Roger E McLendon; Michael R Zalutsky; Ujendra Kumar; Darell D Bigner
Detection of amino-terminal extracellular domain of somatostatin receptor 2 by specific monoclonal antibodies and quantification of receptor density in medulloblastoma.
Roger E McLendon; Gamal Akabani; Henry S Friedman; David A Reardon; Linda Cleveland; Ilkcan Cokgor; James E Herndon; Carol J Wikstrand; Susan T Boulton; Allan H Friedman; Darell D Bigner; Michael R Zalutsky
Tumor resection cavity administered iodine-131-labeled antitenascin 81C6 radioimmunotherapy in patients with malignant glioma: neuropathology aspects.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Carol Wikstrand (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2010: Chien-Tsun Kuan; Kenji Wakiya; James E Herndon; Eric S Lipp; Charles N Pegram; Gregory J Riggins; Ahmed Rasheed; Scott E Szafranski; Roger E McLendon; Carol J Wikstrand; Darell D Bigner
MRP3: a molecular target for human glioblastoma multiforme immunotherapy.
BMC cancer 2010;10():468.
2009: Chien-Tsun Kuan; Carol J Wikstrand; Roger E McLendon; Michael R Zalutsky; Ujendra Kumar; Darell D Bigner
Detection of amino-terminal extracellular domain of somatostatin receptor 2 by specific monoclonal antibodies and quantification of receptor density in medulloblastoma.
Hybridoma (2005) 2009;28(6):389-403.
2007: Roger E McLendon; Gamal Akabani; Henry S Friedman; David A Reardon; Linda Cleveland; Ilkcan Cokgor; James E Herndon; Carol J Wikstrand; Susan T Boulton; Allan H Friedman; Darell D Bigner; Michael R Zalutsky
Tumor resection cavity administered iodine-131-labeled antitenascin 81C6 radioimmunotherapy in patients with malignant glioma: neuropathology aspects.
Nuclear medicine and biology 2007;34(4):405-13.
2006: John C Sok; Francesca M Coppelli; Sufi Thomas; Miriam N Lango; Sichuan Xi; Jennifer L Hunt; Maria L Freilino; Michael W Graner; Carol J Wikstrand; Darell D Bigner; William Gooding; Frank B Furnari; Jennifer Rubin Grandis
Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(17):5064-73.
2006: Chien-Tsun Kuan; Kenji Wakiya; Jeannette M Dowell; James E Herndon; David A Reardon; Michael W Graner; Gregory J Riggins; Carol J Wikstrand; Darell D Bigner
Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(7 Pt 1):1970-82.
2005: David A Rizzieri; Martha Wadleigh; Carol J Wikstrand; Karen P Mann; Filiz Sen; Bercedis L Peterson; Donna Niedzwiecki; Alan D Proia; Darell D Bigner
Tenascin and microvessel stromal changes in patients with non-Hodgkin's lymphoma are isolated to the sites of disease and vary in correlation to disease activity.
Leukemia & lymphoma 2005;46(10):1455-62.
2005: Ranjit K Goudar; Qing Shi; Mark D Hjelmeland; Stephen T Keir; Roger E McLendon; Carol J Wikstrand; Elizabeth D Reese; Charles A Conrad; Peter Traxler; Heidi A Lane; David A Reardon; Webster K Cavenee; Xiao-Fan Wang; Darell D Bigner; Henry S Friedman; Jeremy Rich
Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition.
Molecular cancer therapeutics 2005;4(1):101-12.
2004: Abraham Boskovitz; Carol J Wikstrand; Chien-Tsun Kuan; Michael R Zalutsky; David A Reardon; Darell D Bigner
Monoclonal antibodies for brain tumour treatment.
Expert opinion on biological therapy 2004;4(9):1453-71.
2004: Melinda K Merrill; Günter Bernhardt; John H Sampson; Carol J Wikstrand; Darell D Bigner; Matthias Gromeier
Poliovirus receptor CD155-targeted oncolysis of glioma.
Neuro-oncology 2004;6(3):208-17.
2004: Chris A Learn; Tristan L Hartzell; Carol J Wikstrand; Gary E Archer; Jeremy Rich; Allan H Friedman; Henry S Friedman; Darell D Bigner; John H Sampson
Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant III contributes to the neoplastic phenotype of glioblastoma multiforme.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(9):3216-24.
2004: Jeremy Rich; David A Reardon; Terry Peery; Jeannette M Dowell; Jennifer A Quinn; Kara Penne; Carol J Wikstrand; Lauren B Van Duyn; Janet E Dancey; Roger E McLendon; James C Kao; Timothy T Stenzel; B K Ahmed Rasheed; Sandra Tourt-Uhlig; James E Herndon; James J Vredenburgh; John H Sampson; Allan H Friedman; Darell D Bigner; Henry S Friedman
Phase II trial of gefitinib in recurrent glioblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):133-42.
2003: John H Sampson; Gamal Akabani; Gary E Archer; Darell D Bigner; Mitchel S Berger; Allan H Friedman; Henry S Friedman; James E Herndon; Sandeep Kunwar; Steve Marcus; Roger E McLendon; Alison Paolino; Kara Penne; James M Provenzale; Jennifer Quinn; David A Reardon; Jeremy Rich; Timothy T Stenzel; Sandra Tourt-Uhlig; Carol J Wikstrand; Terence Wong; Roger Williams; Fan Yuan; Michael R Zalutsky; Ira Pastan
Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumors.
Journal of neuro-oncology 2003;65(1):27-35.
2003: Amy B Heimberger; Laura E Crotty; Gary E Archer; Kenneth R Hess; Carol J Wikstrand; Allan H Friedman; Henry S Friedman; Darell D Bigner; John H Sampson
Epidermal growth factor receptor VIII peptide vaccination is efficacious against established intracerebral tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(11):4247-54.
2002: David A Reardon; Gamal Akabani; R Edward Coleman; Allan H Friedman; Henry S Friedman; James E Herndon; Ilkcan Cokgor; Roger E McLendon; Charles N Pegram; James M Provenzale; Jennifer A Quinn; Jeremy Rich; Lorna V Regalado; John H Sampson; Timothy D Shafman; Carol J Wikstrand; Terence Z Wong; Xiao-Guang Zhao; Michael R Zalutsky; Darell D Bigner
Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1389-97.
2002: Carol J Wikstrand; Vanessa R Cole; Laura E Crotty; John H Sampson; Darell D Bigner
Generation of anti-idiotypic reagents in the EGFRvIII tumor-associated antigen system.
Cancer immunology, immunotherapy : CII 2002;50(12):639-52.
2001: Chien-Tsun Kuan; Carol J Wikstrand; Darell D Bigner
EGF mutant receptor vIII as a molecular target in cancer therapy.
Endocrine-related cancer 2001;8(2):83-96.
2001: Ilkcan Cokgor; Gamal Akabani; Henry S Friedman; Allan H Friedman; Michael R Zalutsky; L M Zehngebot; James M Provenzale; CD Guy; Carol J Wikstrand; Darell D Bigner
Long term response in a patient with neoplastic meningitis secondary to melanoma treated with (131)I-radiolabeled antichondroitin proteoglycan sulfate Mel-14 F(ab')(2): a case study.
Cancer 2001;91(9):1809-13.
2000: Chien-Tsun Kuan; Carol J Wikstrand; Gary E Archer; R Beers; Ira Pastan; Michael R Zalutsky; Darell D Bigner
Increased binding affinity enhances targeting of glioma xenografts by EGFRvIII-specific scFv.
International journal of cancer. Journal international du cancer 2000;88(6):962-9.
2000: Ilkcan Cokgor; Gamal Akabani; Chien-Tsun Kuan; Henry S Friedman; Allan H Friedman; R Edward Coleman; Roger E McLendon; Sandra H Bigner; Xiao-Guang Zhao; AM Garcia-Turner; Charles N Pegram; Carol J Wikstrand; Timothy D Shafman; James E Herndon; James M Provenzale; Michael R Zalutsky; Darell D Bigner
Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(22):3862-72.
2000: William Loging; Anita Lal; I-Mei Siu; T L Loney; Carol J Wikstrand; Marco A Marra; C Prange; D D Bigner; Robert L Strausberg; Gregory J Riggins
Identifying potential tumor markers and antigens by database mining and rapid expression screening.
Genome research 2000;10(9):1393-402.
2000: Roger E McLendon; Carol J Wikstrand; MR Matthews; R Al-Baradei; Sandra H Bigner; Darell D Bigner
Glioma-associated antigen expression in oligodendroglial neoplasms. Tenascin and epidermal growth factor receptor.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2000;48(8):1103-10.
2000: John H Sampson; Laura E Crotty; S Lee; Gary E Archer; DM Ashley; Carol J Wikstrand; Laura P Hale; C Small; Glenn Dranoff; Allan H Friedman; Henry S Friedman; Darell D Bigner
Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(13):7503-8.
2000: Chien-Tsun Kuan; Carol J Wikstrand; Darell D Bigner
EGFRvIII as a promising target for antibody-based brain tumor therapy.
Brain tumor pathology 2000;17(2):71-8.
1999: Carol J Wikstrand; Ilkcan Cokgor; John H Sampson; Darell D Bigner
Monoclonal antibody therapy of human gliomas: current status and future approaches.
Cancer metastasis reviews 1999;18(4):451-64.
1998: Darell D Bigner; M T Brown; Allan H Friedman; R Edward Coleman; Gamal Akabani; Henry S Friedman; W L Thorstad; Roger E McLendon; Sandra H Bigner; Xiao-Guang Zhao; Charles N Pegram; Carol J Wikstrand; James E Herndon; N A Vick; Nina Paleologos; Ilkcan Cokgor; James M Provenzale; Michael R Zalutsky
Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2202-12.
1998: Carol J Wikstrand; Craig J Reist; Gary E Archer; Michael R Zalutsky; Darell D Bigner
The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target.
Journal of neurovirology 1998;4(2):148-58.
1997: Carol J Wikstrand; Roger E McLendon; Allan H Friedman; Darell D Bigner
Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII.
Cancer research 1997;57(18):4130-40.
1997: Charleen T Chu; K D Everiss; Carol J Wikstrand; Surinder Batra; Hsing-Jien Kung; D D Bigner
Receptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvIII).
The Biochemical journal 1997;324 ( Pt 3)():855-61.
1997: Craig J Reist; Gary E Archer; Carol J Wikstrand; Darell D Bigner; Michael R Zalutsky
Improved targeting of an anti-epidermal growth factor receptor variant III monoclonal antibody in tumor xenografts after labeling using N-succinimidyl 5-iodo-3-pyridinecarboxylate.
Cancer research 1997;57(8):1510-5.
1996: M T Brown; R Edward Coleman; Allan H Friedman; Henry S Friedman; Roger E McLendon; R Reiman; G J Felsberg; RD Tien; Sandra H Bigner; Michael R Zalutsky; Xiao-Guang Zhao; Carol J Wikstrand; Charles N Pegram; J E Herndon; N A Vick; Nina Paleologos; R K Fredericks; S Clifford Schold; Darell D Bigner
Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial results.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(6):963-72.
1996: Pam Fredman; Carol J Wikstrand; Jan-Eric Månsson; G Reifenberger; Sandra H Bigner; A Rasheed; Lars Svennerholm; Darell D Bigner
In vivo growth conditions suppress the expression of ganglioside GM2 and favour that of lacto series gangliosides in the human glioma D-54MG cell line.
Glycoconjugate journal 1996;13(3):391-9.
1995: S N Kurpad; Xiao-Guang Zhao; Carol J Wikstrand; Surinder Batra; Roger E McLendon; Darell D Bigner
Tumor antigens in astrocytic gliomas.
Glia 1995;15(3):244-56.
1995: Craig J Reist; Gary E Archer; S N Kurpad; Carol J Wikstrand; Ganesan Vaidyanathan; M C Willingham; Moscatello David; Albert J Wong; Darell D Bigner; Michael R Zalutsky
Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts.
Cancer research 1995;55(19):4375-82.
1995: Carol J Wikstrand; Laura P Hale; Surinder Batra; M L Hill; P A Humphrey; S N Kurpad; Roger E McLendon; Moscatello David; Charles N Pegram; Craig J Reist
Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas.
Cancer research 1995;55(14):3140-8.
1995: Darell D Bigner; M Brown; R Edward Coleman; Allan H Friedman; Henry S Friedman; Roger E McLendon; Sandra H Bigner; Xiao-Guang Zhao; Carol J Wikstrand; Charles N Pegram
Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab')2--a preliminary report.
Journal of neuro-oncology 1995;24(1):109-22.
1994: X He; Gary E Archer; Carol J Wikstrand; S L Morrison; Michael R Zalutsky; Darell D Bigner; Surinder Batra
Generation and characterization of a mouse/human chimeric antibody directed against extracellular matrix protein tenascin.
Journal of neuroimmunology 1994;52(2):127-37.
1994: S N Kurpad; Carol J Wikstrand; Darell D Bigner
Immunobiology of malignant astrocytomas.
Seminars in oncology 1994;21(2):149-61.
1994: Surinder Batra; M L Niswonger; Carol J Wikstrand; Charles N Pegram; Michael R Zalutsky; S L Morrison; Darell D Bigner
Mouse/human chimeric Me1-14 antibody: genomic cloning of the variable region genes, linkage to human constant region genes, expression, and characterization.
Hybridoma 1994;13(2):87-97.
1994: Carol J Wikstrand; Pam Fredman; R R McLendon; Lars Svennerholm; Darell D Bigner
Altered expression of ganglioside phenotypes of human gliomas in vivo and in vitro.
Molecular and chemical neuropathology / sponsored by the International Society for Neurochemistry and the World Federation of Neurology and research groups on neurochemistry and cerebrospinal fluid 1994;21(2-3):129-38.
1994: Carol J Wikstrand; Pam Fredman; Lars Svennerholm; Darell D Bigner
Detection of glioma-associated gangliosides GM2, GD2, GD3, 3'-isoLM1 3',6'-isoLD1 in central nervous system tumors in vitro and in vivo using epitope-defined monoclonal antibodies.
Progress in brain research 1994;101():213-23.
1993: Carol J Wikstrand; S D Stanley; P A Humphrey; Charles N Pegram; Gary E Archer; S Kurpad; M Shibuya; Darell D Bigner
Investigation of a synthetic peptide as immunogen for a variant epidermal growth factor receptor associated with gliomas.
Journal of neuroimmunology 1993;46(1-2):165-73.
1993: Carol J Wikstrand; DC Longee; Roger E McLendon; G N Fuller; Henry S Friedman; Pam Fredman; Lars Svennerholm; Darell D Bigner
Lactotetraose series ganglioside 3',6'-isoLD1 in tumors of central nervous and other systems in vitro and in vivo.
Cancer research 1993;53(1):120-6.
1992: Carol J Wikstrand; Pam Fredman; Lars Svennerholm; P A Humphrey; Sandra H Bigner; Darell D Bigner
Monoclonal antibodies to malignant human gliomas.
Molecular and chemical neuropathology / sponsored by the International Society for Neurochemistry and the World Federation of Neurology and research groups on neurochemistry and cerebrospinal fluid 1992;17(2):137-46.
1992: W W Vick; J W Tello; Carol J Wikstrand; X He; DC Longee; Pam Fredman; Lars Svennerholm; Darell D Bigner; W W Johnston; Sandra H Bigner
Application of a panel of antiganglioside monoclonal antibodies to cytologic specimens.
Acta cytologica 1992;36(5):697-705.
1992: X M He; L E Ostrowski; M A von Wronski; Henry S Friedman; Carol J Wikstrand; Sandra H Bigner; A Rasheed; Surinder Batra; Sankar Mitra; Thomas P Brent
Expression of O6-methylguanine-DNA methyltransferase in six human medulloblastoma cell lines.
Cancer research 1992;52(5):1144-8.
1992: J B Ventimiglia; Carol J Wikstrand; L E Ostrowski; M A Bourdon; V A Lightner; Darell D Bigner
Tenascin expression in human glioma cell lines and normal tissues.
Journal of neuroimmunology 1992;36(1):41-55.
1991: Carol J Wikstrand; X M He; G N Fuller; Sandra H Bigner; Pam Fredman; Lars Svennerholm; Darell D Bigner
Occurrence of lacto series gangliosides 3'-isoLM1 and 3',6'-isoLD1 in human gliomas in vitro and in vivo.
Journal of neuropathology and experimental neurology 1991;50(6):756-69.
1991: Rolf Bjerkvig; O Engebraaten; Ole Didrik Laerum; Pam Fredman; Lars Svennerholm; F D Vrionis; Carol J Wikstrand; Darell D Bigner
Anti-GM2 monoclonal antibodies induce necrosis in GM2-rich cultures of a human glioma cell line.
Cancer research 1991;51(17):4643-8.
1991: Henry S Friedman; W Jerry Oakes; Sandra H Bigner; Carol J Wikstrand; Darell D Bigner
Medulloblastoma: tumor biological and clinical perspectives.
Journal of neuro-oncology 1991;11(1):1-15.
1991: X M He; Carol J Wikstrand; Henry S Friedman; Sandra H Bigner; S Pleasure; John Q Trojanowski; Darell D Bigner
Differentiation characteristics of newly established medulloblastoma cell lines (D384 Med, D425 Med, and D458 Med) and their transplantable xenografts.
Laboratory investigation; a journal of technical methods and pathology 1991;64(6):833-43.
1991: Johan Gottfries; Alan K Percy; Jan-Eric Månsson; Pam Fredman; Carol J Wikstrand; H S Friedman; Darell D Bigner; Lars Svennerholm
Glycolipids and glycosyltransferases in permanent cell lines established from human medulloblastomas.
Biochimica et biophysica acta 1991;1081(3):253-61.
1991: Carol J Wikstrand; Henry S Friedman; Darell D Bigner
Medulloblastoma cell-substrate interaction in vitro.
Invasion & metastasis 1991;11(6):310-24.
1991: DC Longee; Carol J Wikstrand; Jan-Eric Månsson; X He; G N Fuller; Sandra H Bigner; Pam Fredman; Lars Svennerholm; Darell D Bigner
Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas.
Acta neuropathologica 1991;82(1):45-54.
1990: Johan Gottfries; Pam Fredman; Jan-Eric Månsson; V P Collins; Hans von Holst; Dawna Duncan Armstrong; Alan K Percy; Carol J Wikstrand; Darell D Bigner; Lars Svennerholm
Determination of gangliosides in six human primary medulloblastomas.
Journal of neurochemistry 1990;55(4):1322-6.
1990: Pam Fredman; Jan-Eric Månsson; Sandra H Bigner; Carol J Wikstrand; Darell D Bigner; Lars Svennerholm
Gangliosides in the human glioma cell line U-118 MG grown in culture or as xenografts in nude rats.
Biochimica et biophysica acta 1990;1045(3):239-44.
1990: G Karlsson; Jan-Eric Månsson; Carol J Wikstrand; Darell D Bigner; Lars Svennerholm
Characterization of the binding epitope of the monoclonal antibody DMAb-1 to ganglioside GM2.
Biochimica et biophysica acta 1990;1043(3):267-72.
1989: F D Vrionis; Carol J Wikstrand; Pam Fredman; Jan-Eric Månsson; Lars Svennerholm; Darell D Bigner
Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines.
Cancer research 1989;49(23):6645-51.
1989: Pam Fredman; Jan-Eric Månsson; Carol J Wikstrand; F D Vrionis; B M Rynmark; Darell D Bigner; Lars Svennerholm
A new ganglioside of the lactotetraose series, GalNAc-3'-isoLM1, detected in human meconium.
The Journal of biological chemistry 1989;264(21):12122-5.
1989: Johan Gottfries; J E Mansson; Pam Fredman; Carol J Wikstrand; H S Friedman; Darell D Bigner; Lars Svennerholm
Ganglioside mapping of a human medulloblastoma xenograft.
Acta neuropathologica 1989;77(3):283-8.
1989: X He; Carol J Wikstrand; Pam Fredman; Jan-Eric Månsson; Lars Svennerholm; Darell D Bigner
GD3 expression by cultured human tumor cells of neuroectodermal origin.
Acta neuropathologica 1989;79(3):317-25.
1989: X M He; Stephen Xavier Skapek; Carol J Wikstrand; Henry S Friedman; John Q Trojanowski; J T Kemshead; H B Coakham; Sandra H Bigner; Darell D Bigner
Phenotypic analysis of four human medulloblastoma cell lines and transplantable xenografts.
Journal of neuropathology and experimental neurology 1989;48(1):48-68.
1988: Henry S Friedman; Peter C Burger; Sandra H Bigner; John Q Trojanowski; Garrett M Brodeur; X M He; Carol J Wikstrand; Joanne Kurtzberg; Michael Berens; Edward C Halperin
Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc.
The American journal of pathology 1988;130(3):472-84.
1988: Y S Lee; D E Bullard; Michael R Zalutsky; R Edward Coleman; Carol J Wikstrand; Henry S Friedman; E V Colapinto; Darell D Bigner
Therapeutic efficacy of antiglioma mesenchymal extracellular matrix 131I-radiolabeled murine monoclonal antibody in a human glioma xenograft model.
Cancer research 1988;48(3):559-66.
1988: F D Vrionis; Carol J Wikstrand; Darell D Bigner
Relevance for neurobiology and neurooncology of antigens of malignant gliomas as defined by monoclonal antibodies.
Annals of the New York Academy of Sciences 1988;540():64-77.
1987: W W Vick; Carol J Wikstrand; D E Bullard; J Kemshead; H B Coakham; J Schlom; W W Johnston; Darell D Bigner; Sandra H Bigner
The use of a panel of monoclonal antibodies in the evaluation of cytologic specimens from the central nervous system.
Acta cytologica 1987;31(6):815-24.
1983: M A Bourdon; Carol J Wikstrand; H Furthmayr; T J Matthews; Darell D Bigner
Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.
Cancer research 1983;43(6):2796-805.
1982: Carol J Wikstrand; M A Bourdon; Charles N Pegram; Darell D Bigner
Human fetal brain antigen expression common to tumors of neuroectodermal tissue origin.
Journal of neuroimmunology 1982;3(1):43-62.
1981: Sandra H Bigner; D E Bullard; Charles N Pegram; Carol J Wikstrand; D D Bigner
Relationship of in vitro morphologic and growth characteristics of established human glioma-derived cell lines to their tumorigenicity in athymic nude mice.
Journal of neuropathology and experimental neurology 1981;40(4):390-409.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.